Product Code: MCP-3336
This report analyzes the worldwide markets for Imaging Agents in US$ by the following Product Segments: Contrast Media (X-Ray/CT, MRI, & Ultrasound), and Diagnostic Radiopharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 52 companies including many key and niche players such as -
Aytu BioScience, Inc.
Bayer Healthcare Pharmaceuticals
Bracco Diagnostics, Inc.
Curium
Daiichi Sankyo Company Limited
Bracco-Eisai Co., Ltd.
Table of Contents
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
Product Definitions and Scope of Study
- A. Contrast Media
- X-Ray/CT Contrast Media
- Magnetic Resonance Imaging (MRI) Contrast Media
- Ultrasound Contrast Media
- B. Diagnostic Radiopharmaceuticals
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
- Imaging Agents: Providing Brighter and Clearer Images for Effective Clinical Diagnosis
- Growing Need for Early Disease Diagnosis Fosters Demand for Imaging Agents
- Major Growth Drivers in a Nutshell
- Select Market Growth Restraints
- Contrast Media: Giving Way to Contemporary Offshoots
- X-ray/CT Segment Continues to Lead Contrast Media Market
- Developed Economies Face Threat from Rising Demand for Contrast Agents in Asia-Pacific
- Diagnostic Radiopharmaceuticals to Outdo Contrast Media
- Nuclear Medicine: A Potential Growth Avenue for Dx Radiopharmaceuticals
- Select PET and SPECT Radioisotopes Used in Nuclear Medicine
- Select Cardiology and Oncology Radiopharmaceuticals
- Developed Markets Rule the Imaging Agents Market, Developing Regions to Spearhead Future Growth
2. SEGMENTAL OVERVIEW AND COMPETITIVE LANDSCAPE
- Market Structure
- Key Market Participants
- Contrast Media
- Popular Brands of Contrast Agents
- X-ray Contrast Media
- Table 1: Annual Sales of Select Iodinated Contrast Agents for 2016 & 2017 (In US$ Million) (includes corresponding Graph/Chart)
- MRI Contrast Media
- Market Scenario
- Key Players in the MRI Market
- List of FDA Approved Gadolinium-Based Contrast Agents (GBCA) for CNS MRI
- List of EMA Approved Gd Chelated Contrast Agents
- Controversies over GBCAs Refuse to Die Down
- A Comparison of Select Gadolinium-based Contrast Agents
- Select GBCA-Induced Toxicities
- Gadolinium Accumulation in Brain - A Major Concern for the Market
- FDA Finds Concerns over Accumulation of Gadolinium Used in MRI Brain to be Unfounded
- FDA Issues Drug Safety Communication for Gadolinium-Based MRI Contrast Agents
- EMA Places Restrictions on Use of Linear Gadolinium Agents for Body Scans
- Competitive Re-arrangement Surfaces as Safety Concerns on GBCAs Reach their Peak
- Table 2: Annual Sales of Select Gadolinium-Based Contrast Agents for 2016 & 2017 (In US$ Million) (includes corresponding Graph/Chart)
- Glucose - Can it Replace GBCAs for MRIs?
- Ultrasound Contrast Media
- Limited System Use Curtails Demand for Ultrasound Contrast Agents, Potential for Further Growth Exists
- CEUS and Ultrasound Contrast Agents - A Dichotomy in Approach in Europe and the US
- A Comparison of Approved Ultrasound Contrast Agents
- Approved Ultrasound Contrast Agents by Country and Application
- Contrast Media API Production - Still Largely In-house
- A Peek into API Supplier Space for Select Contrast Media
- Diagnostic Radiopharmaceuticals
- Market Overview
- Commonly Used Diagnostic Radiopharmaceutical Agents
- Major Isotopes and their Diagnostic Applications
- Select FDA Approved Diagnostic Radiopharmaceuticals by Indication
- Prospects for Radiopharmaceutical Agents in PET and SPECT Appear Brighter
3. MARKET TRENDS & ISSUES
- Sustained Expansion of Molecular Imaging Platform Presents Positive Outlook
- Novel Radiopharmaceuticals Add New Dimensions to Molecular Imaging
- Latest Radiopharmaceuticals to Benefit Molecular Imaging
- Microbubbles/Ultrasound Contrast Agents Set for Strong Growth
- Growing Interest in Image Guided Surgery Offers New Opportunities
- Role of Near-Infrared Contrast Agents for Image Guided Surgery
- Fluorescence Optical Imaging - Opens New Avenues
- Coronary CT Angiography Opens Up Opportunities for Contrast Agents
- List of Iodine-Containing Contrast Agents for Coronary CT Angiography
- Targeted Imaging - A Game Changer in the Making
- Rising Clinical Acceptance of MRI Systems Augurs Well for Contrast Agents Market
- Table 3: Global Number of MRI Procedures in Million for the Years 2014, 2016 and 2018 (includes corresponding Graph/Chart)
- Researchers Develop Iron Oxide-based Contrast Agent for MRI
- Nanomaterials Taking the Center Stage
- New Nanoparticle Contrast Agents on the Horizon Show Promise
- Gadolinium Coated Nanoparticles - A Promising Imaging Agent
- Growing Focus on Development of Gold Nanoparticles in X-Ray Imaging
- Imaging Agents Make a Welcome Impact in the Field of Alzheimer's Disease
- List of FDA Approved Alzheimer's Diagnostic Imaging Agents
- Contrast-Enhanced Tomosynthesis Expands Opportunities
- Hyperpolarized Gases as Contrast Agents
- Multi-Modal Imaging: Combating Contrast Medium Inconsistencies
- Falling Prices Turn on the Heat
- Ultrasound Contrast Agents in Diagnosis of Kidney Ailments
- PET: A Prime Growth Driver for Diagnostic Radiopharmaceuticals
- Innovative Radiotracers to Boost Cardiac Applications for SPECT and PET Modalities
- A Peek at Global CVD Stats
- Table 4: Global Annual Medical Cost of CVD in US$ Billion for the Years 2010, 2015, 2020, 2025 and 2030 (includes corresponding Graph/Chart)
- Table 5: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)
- Echocardiography Examinations - Improving Diagnostic Quality through Contrast Agents
- Opportunities on Rise for Fluorine-Based Myocardial Perfusion Agents
- Unfounded Fears of Radiation Exposure: A Major Concern for Nuclear Diagnostics
- Rising Incidence of Cancer - A Major Growth Driver
- World Cancer Statistics - Incidence and Mortality Data
- Table 6: World Cancer Incidence (2012): Number of New Cancer Cases Reported in Thousands by Geographic Region (includes corresponding Graph/Chart)
- Table 7: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
- Improving Healthcare Expenditure to Foster Growth
- Table 8: Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart)
- Table 9: Per Capita Healthcare Spending (in $) in Select Developed Countries for the Year 2016 (includes corresponding Graph/Chart)
- Aging Population - A Vital Demography
- Table 10: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
- Table 11: Life Expectancy at Birth in Years of People in Select Countries (2017) (includes corresponding Graph/Chart)
- A Peek into Pricing Dynamics
- Packaging of Contrast Agents - An Overview
- Global Supply Shortages Restrains Radiopharmaceuticals Market
- Price Sensitivity & Competition from Alternatives
- Lack of Dosage Standards for Pediatric Patients Limits Radiopharmaceutical Efficacy
- Reimbursement Scenario
- Europe
- United States
4. GLOBAL MEDICAL IMAGING MARKET - AN OVERVIEW
- Medical Imaging - Changing the Landscape of Clinical Diagnosis
- Table 12: Global Medical Imaging Equipment Market by Modality (2017): Percentage Breakdown of Value for CT, MRI, Nuclear, Ultrasound and X-Ray (includes corresponding Graph/Chart)
- Table 13: Global Medical Imaging Equipment Market by Geographic Region (2017): Percentage Breakdown of Value for China, Europe, Japan, North America and Rest of World (includes corresponding Graph/Chart)
- Key Trends in the Global Medical Imaging Market
- Growing Need for Medical Diagnostic Equipment, Outside Western World
- Healthcare Providers Seeking Newer Cost-Effective Methods
- Cost Related Issue of Electronic Technology Used for Diagnostic Purposes
- Upgradation of Existing Imaging Equipment
- Growing Prominence of 3D Technology in Medical Applications
- Archaic X-Ray Imaging Modalities Paving Way for Digital X-Rays
- Ultrasound Holds its Fort in the Medical Imaging Market
- Technological Advancements Favor MRI Market
- Table 14: Global MRI Market - Percentage Breakdown of Procedure Volume by Application for 2017 (includes corresponding Graph/Chart)
- Nuclear Medicine Imaging Equipment Presents Lucrative Growth Opportunities
- Table 15: Worldwide Installed Base of Nuclear Imaging Equipment by Modality (2016) Percentage Breakdown of Units Installed for PET and SPECT (includes corresponding Graph/Chart)
- Hybrid Imaging to Herald a New Era of Diagnosis
- Hybrid PET/MRI Systems: A New Fusion
- Unfounded Fears of Radiation Exposure Hinder Growth
- Bottlenecks in Developing Markets
- Use of Contrast Agents in Other Imaging Modalities
- Fluoroscopy
- Computed Tomography
5. PRODUCT OVERVIEW
- Contrast Agents
- Contrast Media: How Do They Function?
- Evolution of Contrast Media: A Profile
- Bismuth Nitrate: Beginning of Contrast Agents
- Imaging Agents: Significant Developments in the Last Fifty Years
- Schering Develops First Intravenous Contrast Agent
- MRI: Creating a New Era for Contrast Agents
- A Peek into the Finer Points of Differences Among Contrast Media
- Second Generation Non-Ionic Contrast Agents: An Introduction
- Choice of the Contrast Medium: A Weighty Decision
- Factors Affecting choice of Imaging Agents
- Taxonomy
- Types of Contrast Media
- X-Ray Contrast Medium
- First Generation High Osmolar Contrast Media
- Second Generation Low Osmolar Contrast Media or LOCM
- Table 16: Comparative Analysis of Structure of Non-ionic and ionic X-ray Contrast Media (includes corresponding Graph/Chart)
- MRI Contrast Medium
- Role of Contrast Enhancement in MR Angiography (MRA)
- MRI Contrast Agents for the Liver
- Paramagnetic Extracellular Contrast Agents
- Hepatobiliary Gadolinium Chelates
- Superparamagnetic Iron Oxide Particles
- Ultrasound Contrast Medium
- Ultrasonographic Contrast Media: What Are They?
- Ultrasound Contrast Enhancement in Cardiology
- Functionalities of Vascular Ultrasound Contrast Agents
- Diagnostic Radiopharmaceuticals
- A Delineate of Diagnostic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals: A Technical Run-Through
- Applications
- Classification
- Cardiology Diagnostics
- Non-cardiology Diagnostics
- Molecular Imaging Modalities in Radiopharmaceutical Diagnostics
- Planar Imaging
- Positron Emission Tomography (PET)
- Commonly used Radioisotopes in PET Scans
- Major PET Isotopes and their Applications
- Single Photon Emission Computed Tomography (SPECT)
- Applications of SPECT
- Commonly used Radioisotopes in SPECT Scans
6. TECHNOLOGY DYNAMICS
- Proprietary Technologies Making In-Roads
- Advanced Magnetics' Proprietary Colloidal Superparamagnetic Particle Technology
- Enzon's Single Chain Antigen-Binding Technology
- Immunomedics' Antibody Technology
- First Generation
- Second Generation
- Third Generation
- NeoRx's "Painting the Target" Technology
- Stage - I
- Stage - II
- Stage - III
- Gas Encapsulation Technology for Ultrasound Contrast Media
- Pharmacyclics' Texaphyrin Technology
- Regulatory Bodies
- Entry Barriers
- Research Driven Markets
- Highly Competitive Market
- Economies of Scale
- Substitutes in Agents Manufacturing
- New X-ray Diagnostic Agents
- Amide-based Macrocyclic Ligands - Potential MRI Agents
- Gadolinium (III) Complexes - Potential MRI Contrast Agents
- Metal-Containing Compounds Act As Potential Contrast Agents
- Therapeutic Applications
- Diagnostic Applications
- Magnetic Gels as Potential MRI Contrast Agents
- PFCs as Diagnostic Contrast Agents
- Saline Flushes To Help Ensure Accurate Delivery of Contrast Agents
7. PRODUCT INNOVATIONS/INTRODUCTIONS/ APPROVALS
- NanoHybrids Introduces PAtrace Contrast Agent
- Ligand Commences Initiative to Develop New Captisol-Enabled Contrast Agents
- Guerbet Launches Contrast&Care(r)
- GE Healthcare Launches Clariscan(tm) Gadolinium-based Contrast Agent
- Piramal Imaging Announces New Research on PET Imaging Tracers
- Bracco Bags FDA Approval for TAGITOL V for Use in Colon CT Imaging
- Guerbet Wins FDA Approval for Dotarem(r) Use in MRI for Pediatric Patients for CNS Scanning
- Lantheus Begins Shipment of Xenon Xe 133 Gas
- Otsuka Launches ORALTAG(tm) in the US
- Advanced Accelerator Applications Receives FDA Approval for Netspot
- Blue Earth Diagnostics Secures FDA Approval for Axumin(tm)
- Bayer Obtains FDA Approval for Gadavist(r) for MRA for Supra-aortic Arteries
- Bracco Secures FDA Clearance for LUMASON in Ultrasonography of the Liver for Lesion Characterization
- Bracco Obtains FDA Clearance for READI-CAT(r) 2 and READI-CAT(r) 2 SMOOTHIE NDA
- Bracco Bags FDA Approval for E-Z-HD for GI Tract Radiohraphic Exams
8. RECENT INDUSTRY ACTIVITY
- Novartis Acquires Advanced Accelerator Applications
- Bracco Imaging Takes Over SurgVision
- Mallinckrodt Divests Nuclear Imaging Business to IBA Molecular
- GE Healthcare Inks Agreement to Supply Radiopharmaceuticals to HealthTrust
- Cell>Point Inks Licensing Agreement with UEP for Oncardia
- FluoroPharma Inks Agreement to Take Over Ground Fluor Pharmaceuticals
- Bracco Diagnostics's LUMASON(r) Obtains Innovative Technology Designation from Vizient
- Blue Earth Diagnostics Establishes Operations in the US
- Ipsen and 3B Pharmaceuticals Ink Licensing Deal for Oncology Radiopharmaceuticals
- Lantheus Divests Gludef(r) Business in Canada to Isologic
9. FOCUS ON SELECT PLAYERS
- Aytu BioScience, Inc. (USA)
- Bayer Healthcare Pharmaceuticals (Germany)
- Bracco Diagnostics, Inc. (USA)
- Curium (France)
- Daiichi Sankyo Company Limited (Japan)
- Bracco-Eisai Co., Ltd (Japan)
- Eli Lilly and Company (USA)
- GE Healthcare (UK)
- Guerbet Group (France)
- Lantheus Medical Imaging, Inc. (USA)
- Piramal Imaging SA (Switzerland)
10. GLOBAL MARKET PERSPECTIVE
- Table 17: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 18: World Historic Review for Imaging Agents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 19: World 14-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
- Table 20: World Recent Past, Current & Future Analysis for Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 21: World Historic Review for Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 22: World 14-Year Perspective for Contrast Media by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
- Table 23: World Recent Past, Current & Future Analysis for Contrast Media by Product Segment - X-Ray/CT, MRI and Ultrasound Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 24: World Historic Review for Contrast Media by Product Segment - X-Ray/CT, MRI and Ultrasound Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 25: World 14-Year Perspective for Contrast Media by Product Segment - Percentage Breakdown of Dollar Sales for X-Ray/CT, MRI and Ultrasound Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
- Table 26: World Recent Past, Current & Future Analysis for X-Ray/CT Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 27: World Historic Review for X-ray/CT Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 28: World 14-Year Perspective for X-Ray/CT Contrast Media by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
- Table 29: World Recent Past, Current & Future Analysis for MRI Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 30: World Historic Review for MRI Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 31: World 14-Year Perspective for MRI Contrast Media by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
- Table 32: World Recent Past, Current & Future Analysis for Ultrasound Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 33: World Historic Review for Ultrasound Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 34: World 14-Year Perspective for Ultrasound Contrast Media by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
- Table 35: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 36: World Historic Review for Diagnostic Radiopharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 37: World 14-Year Perspective for Diagnostic Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
III. MARKET
1. THE UNITED STATES
- A. Market Analysis
- Current and Future Analysis
- Contrast Media - Losing Share to Diagnostic Radiopharmaceuticals Segment
- Table 38: Leading Players in the US Contrast Media Market (2017): Percentage Breakdown of Dollar Sales for Bayer, Bracco, GE Healthcare, Guerbet and Others (includes corresponding Graph/Chart)
- Diagnostic Radiopharmaceuticals to Drive Future Growth
- Table 39: US Diagnostic Radiopharmaceuticals Market by Procedure (2017): Percentage Breakdown of Revenues for PET and SPECT (includes corresponding Graph/Chart)
- Table 40: US Market for Diagnostic Radiopharmaceuticals Agents (2017): Percentage Breakdown of Value Sales for Cardiology and Non-Cardiology Applications (includes corresponding Graph/Chart)
- Growth Stimulants in a Nut Shell
- Demographic Changes Offer Growth Opportunities
- Table 41: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
- Dynamics of Pricing
- Key Trends and Issues
- Expanding Applications to Stimulate Growth in Dx Radiopharmaceuticals Market
- New Oncology, Neurology Agents to Boost Growth
- List of FDA Approved Alzheimer's Diagnostic Imaging Agents
- Alzheimer's Stats
- Table 42: Prevalence of Alzheimer's Disease in the US (2018): Percentage Breakdown of Patient Population by Age Group (includes corresponding Graph/Chart)
- Table 43: Top 15 US States Ranked by Alzheimer's Prevalence for 2018 & 2025 (includes corresponding Graph/Chart)
- Nuclear Cardiology Products Drive Diagnostic Radiopharmaceuticals Market
- Cardiovascular Imaging to Lead Volume Growth
- PET Procedures in the US on Rise
- Growing Adoption of SPECT/CT
- Rising Incidence of Cancer - A Major Growth Driver
- Table 44: New Cancer Cases by Gender and Affected Site in the US (2018) (includes corresponding Graph/Chart)
- Isotope Shortage Emerges as a Key Issue
- Shortage of Medical Isotopes Looms Large
- Table 45: Nuclear Reactors Producing 99Mo: Potential Annual Irradiation Capacities/Year and Estimated Year of Ceasing Production
- Table 46: Annual Irradiation Capacities and Current Status of New Irradiation Projects Under Development Worldwide for Production of Mo-99/Tc-99m
- US Approve Medical Isotope Making System to Mitigate Concerns over Isotope Shortage
- Fluorodeoxyglucose (FDG) Market in the US: An Overview
- Regulatory Environment
- Provisions Regarding Off-Label Usage of Contrast Media
- Reimbursement Issues
- Contrast Agents and Diagnostic Radiopharmaceuticals Bundled As Supplies
- Product Launches/Approvals
- Strategic Corporate Developments
- Key Players
- B. Market Analytics
- Table 47: US Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 48: US Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 49: US 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
2. CANADA
- A. Market Analysis
- Current and Future Analysis
- An Overview of Medical Imaging Market
- Regulatory and Legal Restrictions
- Canadian Scientists Gear up to find Remedy for Mo-99 Supply Shortages
- Regulatory and Legal Restrictions
- Strategic Corporate Development
- B. Market Analytics
- Table 50: Canadian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 51: Canadian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 52: Canadian 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
3. JAPAN
- A. Market Analysis
- Current and Future Analysis
- Healthcare in Japan
- Key Players
- B. Market Analytics
- Table 53: Japanese Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 54: Japanese Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 55: Japanese 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
4. EUROPE
- A. Market Analysis
- Outlook
- Cancer: A Major Driver for Imaging Agents
- Table 56: Number of New Cancer Cases in Europe (in Million): 2012-2030 (includes corresponding Graph/Chart)
- Aging Demography - An Opportunity Indicator
- Table 57: Population Breakup by Age Group for European Countries for 2017 (includes corresponding Graph/Chart)
- New Applications and Products Augur Well for the Radiopharmaceuticals Market
- EMA Places Restrictions on the Use of Linear Gadolinium Agents for Body Scans
- Reimbursement
- Distribution Structure
- B. Market Analytics
- Table 58: European Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 59: European Historic Review for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 60: European 14-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
- Table 61: European Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 62: European Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 63: European 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
4a. FRANCE
- A. Market Analysis
- Current and Future Analysis
- Strategic Corporate Developments
- Select Players
- B. Market Analytics
- Table 64: French Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 65: French Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 66: French 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
4b. GERMANY
- A. Market Analysis
- Current and Future Analysis
- Bayer Healthcare Pharmaceuticals - A Key Player
- B. Market Analytics
- Table 67: German Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 68: German Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 69: German 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
4c. ITALY
- A. Market Analysis
- Current and Future Analysis
- Strategic Corporate Development
- B. Market Analytics
- Table 70: Italian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 71: Italian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 72: Italian 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
- A. Market Analysis
- Current and Future Analysis
- Strategic Corporate Developments
- GE Healthcare - A Major UK-Based Player
- B. Market Analytics
- Table 73: UK Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 74: UK Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 75: UK 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
4e. SPAIN
- Market Analysis
- Table 76: Spanish Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 77: Spanish Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 78: Spanish 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
4f. RUSSIA
- Market Analysis
- Table 79: Russian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 80: Russian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 81: Russian 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
- A. Market Analysis
- Current and Future Analysis
- Strategic Corporate Developments
- Piramal Imaging SA (Switzerland) - A Key Player
- B. Market Analytics
- Table 82: Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 83: Rest of Europe Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 84: Rest of Europe 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
5. ASIA-PACIFIC
- A. Market Analysis
- Current and Future Analysis
- Rising Healthcare Spending and Aging Population Spell Market Growth
- Table 85: Over 60 Years Individuals as % of Total Population in Select Asian Countries: 2017 (includes corresponding Graph/Chart)
- India & China Offer Significant Growth Opportunities
- B. Market Analytics
- Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 87: Asia-Pacific Historic Review for Imaging Agents by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 88: Asia-Pacific 14-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
- Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 90: Asia-Pacific Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 91: Asia-Pacific 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
5a. CHINA
- A. Market Analysis
- Current and Future Analysis
- Select Products Market in China's Contrast Agents Market
- Medical Imaging Equipment Market - An Overview
- Increasing Expenditure on the Healthcare Sector Boost Market Adoption
- Competitive Scenario
- Table 92: Leading Players in the Chinese CT Contrast Agents Market (2015): Percentage Breakdown of Value Sales for Select Agents (includes corresponding Graph/Chart)
- Table 93: Leading Players in the Chinese MRI Contrast Agents Market (2015): Percentage Breakdown of Value Sales for Select Agents (includes corresponding Graph/Chart)
- Strategic Corporate Development
- B. Market Analytics
- Table 94: Chinese Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 95: Chinese Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 96: Chinese 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
5b. INDIA
- A. Market Analysis
- India - A High Potential Market
- Regulatory Mechanism for Guiding Isotope Production and Distribution
- CT Scanners Market in India - An Overview
- Table 97: Indian CT Scanners Market by Segment (2017E): Percentage Breakdown of Unit Sales for <16 Slice, 16 to 64 Slice, >64 to 128 Slice, and >128 Slice (includes corresponding Graph/Chart)
- PET/CT Scanning Gathers Momentum in India
- J.B.Chemicals and Pharmaceuticals Ltd - A Key Player
- B. Market Analytics
- Table 98: Indian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 99: Indian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 100: Indian 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
- A. Market Analysis
- Current and Future Analysis
- Korea
- B. Market Analytics
- Table 101: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 102: Rest of Asia-Pacific Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 103: Rest of Asia-Pacific 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
6. MIDDLE EAST & AFRICA
- Market Analysis
- Table 104: Middle East & African Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 105: Middle East & African Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 106: Middle East & African 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
7. LATIN AMERICA
- A. Market Analysis
- Current and Future Analysis
- Private Sector Boosts Healthcare Segment
- B. Market Analytics
- Table 107: Latin American Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 108: Latin American Historic Review for Imaging Agents by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 109: Latin American 14-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin American Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
- Table 110: Latin American Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 111: Latin American Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 112: Latin American 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
7a. BRAZIL
- Market Analysis
- Table 113: Brazilian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 114: Brazilian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 115: Brazilian 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
7b. REST OF LATIN AMERICA
- Market Analysis
- Table 116: Rest of Latin America Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 117: Rest of Latin America Historic Review for Imaging Agents by Product Segment - Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 118: Rest of Latin America 14-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-Ray/CT, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
